PubMed:30592011 / 738-938 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/30592011","sourcedb":"PubMed","sourceid":"30592011","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/30592011","text":"One of the safety concerns is the development of lung pathology in mice and non-human primates, which is most likely related to the strongly reduced LRRK2 protein levels after LRRK2 kinase inhibition.","tracks":[{"project":"PubMed_ArguminSci","denotations":[{"id":"T6","span":{"begin":0,"end":200},"obj":"DRI_Background"}],"attributes":[{"subj":"T6","pred":"source","obj":"PubMed_ArguminSci"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubMed_ArguminSci","color":"#ccec93","default":true}]}]}}